Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Obstet Gynecol. 2019 May;133(5):943–951. doi: 10.1097/AOG.0000000000003231

Figure 3.

Figure 3.

Change in opioid pharmacotherapy utilization during pregnancy by Medicaid geographic region in Pennsylvania, 2009–2015. Percent change in buprenorphine utilization (A), percent change in methadone utilization (B), and percent change in no pharmacotherapy observed (C).